OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
Anne M. Spanjaart, Elise R. A. Pennings, Milan Kos, et al.
JCO Oncology Practice (2022) Vol. 19, Iss. 3, pp. e407-e416
Open Access | Times Cited: 8

Showing 8 citing articles:

Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di, Christopher T. Su, Andrew J. Cowan, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024) Vol. 65, Iss. 10, pp. 1418-1429
Closed Access | Times Cited: 6

Quality of Life and Prognostic Awareness in Caregivers of Patients Receiving Chimeric Antigen Receptor T Cell Therapy
Anna Barata, Tejaswini Dhawale, Richard Newcomb, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 4, pp. 452.e1-452.e11
Closed Access | Times Cited: 5

Unmet needs and lived experience of patients receiving CAR T-cell therapy
P.G. O’Shea, P. Connor Johnson, Areej El‐Jawahri, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-11
Closed Access

OUTREACH: Phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL
Yuliya Linhares, César O. Freytes, Mohamad Cherry, et al.
Blood Advances (2024) Vol. 8, Iss. 23, pp. 6114-6126
Open Access | Times Cited: 2

Development of a conceptual framework for an electronic patient-reported outcome (ePRO) system measuring symptoms and impacts of CAR T-cell therapies in patients with haematological malignancies
Foram Khatsuria, Christel McMullan, Olalekan Lee Aiyegbusi, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 10, pp. e476-e488
Closed Access | Times Cited: 2

Cellular therapy in lymphoma
Anna Sureda, Pieternella J. Lugtenburg, Marie José Kersten, et al.
Hematological Oncology (2023) Vol. 42, Iss. 6
Closed Access | Times Cited: 5

In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
Christopher E. Dandoy, J. P. Adams, Andrew Artz, et al.
Transplantation and Cellular Therapy (2024) Vol. 30, Iss. 10, pp. 942-954
Closed Access | Times Cited: 1

Page 1

Scroll to top